May 23, 2018 - Dr. Reddy's bottom line and top line suffered a year-over-year decline, in the fourth quarter of fiscal 2018.
May 10, 2018 - This beaten-down biotech stock should still be a solid winner for patient investors.
Mar 29, 2018 - BioMarin's (BMRN) MAA submission for its pipeline PKU candidate, pegvaliase, gets accepted in the EU. The same is under priority review in the United States with decision awaited this May.
Mar 14, 2018 - The biotech's CFO talks about the future for ozanimod, challenges to Revlimid, and more at the Barclays healthcare conference.
Mar 12, 2018 - Zacks Industry Outlook Highlights: AstraZeneca, Bayer, Dr. Reddy's Laboratories, Teva Pharmaceuticals and Adamas Pharmaceuticals
Mar 09, 2018 - Pharma Stocks Weighed Down by Competition, Generic Pressure
Feb 15, 2018 - J&J (JNJ) Gets FDA approval for Erleada (apalutamide) for the treatment of non-metastatic castration-resistant prostate cancer.
Jan 25, 2018 - Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) Q3 2018 Earnings Conference Call January 25, 2018 8:00 AM ET Executives Saunak Savla – Head-Investor Relations Saumen Chakraborty – President, Chief Financial
Jan 25, 2018 - Dr. Reddy's (RDY) earnings per American Depositary Share were down 27.3% in third-quarter fiscal 2018 from the year-ago quarter while the top line beat the prior-year figure.
Dec 20, 2017 - Want to cash in on the pharmaceutical boom? Generic drugs add to the arguments for giving Pfizer, Novartis and Mylan a closer look.